Skip to main content

Partial-thickness Burn Wounds

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Kerecis
KerecisIceland - Isafjordur
1 program
Intact fish skin graftPHASE_41 trial
Active Trials
NCT07326657Enrolling By Invitation65Est. Jan 2029

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
KerecisIntact fish skin graft

Clinical Trials (1)

Total enrollment: 65 patients across 1 trials

NCT07326657KerecisIntact fish skin graft

Evaluating Whether Intact Fish Skin Graft Can Decrease the Need for Autograft in the Treatment of Deep Partial-Thickness Burns

Start: Jan 2026Est. completion: Jan 202965 patients
Phase 4Enrolling By Invitation

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.